| Literature DB >> 1606517 |
Abstract
IVIG is the definitive therapy for primary immunodeficiency diseases associated with hypogammaglobulinemia or specific antibody deficiencies. Administration of IVIG is relatively safe, but occasional adverse reactions are usually self-limited and generally are not an indication for stopping therapy. Home administration of IVIG has found increasing favor among treating physicians and their patients.Entities:
Mesh：
Substances：
Year: 1992 PMID： 1606517 DOI： 10.1007/978-1-4612-0417-6_1
Source DB: PubMed Journal: Clin Rev Allergy ISSN： 0731-8235